Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis.

Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis.

AIMS: Renin-angiotensin inhibitors in Type 2 diabetes and microalbuminuria reduce renal and cardiovascular risk, but evidence supporting use of maximal tolerated dose is unclear. We aimed to determine the extent of renin-angiotensin inhibitor dose-dependent effects from randomized trials carried ou...

Full description

Bibliographic Details
Main Authors:	Blacklock, C, Hirst, J, Taylor, K, Stevens, R, Roberts, N, Farmer, A
Format:	Journal article
Language:	English
Published:	2011

Similar Items

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy.
by: Hirst, J, et al.
Published: (2012)

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy
by: Taylor, K, et al.
Published: (2012)

U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM.
by: Dudley, C, et al.
Published: (1995)

Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review
by: Frederik Persson, et al.
Published: (2016-07-01)

Persistent microalbuminuria after treatment with renin-angiotensin axis blockers: causes and results of treatment intensification
by: NR Robles, et al.
Published: (2011-09-01)

Resolving the mysteries of the renin-angiotensin system in diabetes
by: Atsuhiro Ichihara
Published: (2006-12-01)

The renin–angiotensin system and diabetes: An update
by: Antônio Ribeiro-Oliveira Jr, et al.
Published: (2008-08-01)

Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus
by: Bilge Volkan-Salanci, et al.
Published: (2009-03-01)

Renoprotection in Type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockers
by: Pauline A Swift, et al.
Published: (2001-09-01)

Review: The renin-angiotensin-aldosterone system and the eye in diabetes
by: W David Strain, et al.
Published: (2002-12-01)

Renin-angiotensin and kallikrein-kinin systems in diabetic retinopathy
by: Igić Rajko
Published: (2019-01-01)

The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes
by: Mats Bojestig, et al.
Published: (2000-12-01)

Review: Renal protection by inhibition of the renin-angiotensin-aldosterone system
by: Tomas Berl
Published: (2009-03-01)

Cardioprotective and Antifibrotic Effects of Low-Dose Renin–Angiotensin–Aldosterone System Inhibitors in Type 1 Diabetic Rat Model
by: Dora B. Balogh, et al.
Published: (2023-12-01)

Renin–angiotensin system inhibitor use and colorectal cancer risk and mortality: A dose–response meta analysis
by: Xia Chen, et al.
Published: (2020-07-01)

The Interaction Of Renin-Angiotensin And Sympathetic Nervous Systems In Diabetes And Hypertension
by: Lazhari, Mohamed Ibrahim A. Ali
Published: (2004)

Review: The renin-angiotensin-aldosterone system, blockade and diabetic nephropathy
by: Norman K Hollenberg
Published: (2001-03-01)

Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe?
by: Bilgehan Karadağ
Published: (2020-07-01)

The angiotensin II-renin feedback and the “negative role” of renin release
by: Michel Azizi
Published: (2008-03-01)

Genetic variation in the renin—angiotensin system, use of renin—angiotensin system inhibitors and the risk of myocardial infarction
by: Anke-Hilse Maitland-van der Zee, et al.
Published: (2011-09-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System
by: Akira Nishiyama, et al.
Published: (2010-01-01)

Renin-Angiotensin System Gene Variants and Type 2 Diabetes Mellitus: Influence of Angiotensinogen
by: Joyce-Tan, S.M., et al.
Published: (2016)

Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus
by: Hans-Henrik Parving
Published: (2000-03-01)

The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review
by: João Pedro Thimotheo Batista, et al.
Published: (2023-07-01)

Diabetes-induced stimulation of the renin-angiotensin system in the rat brain cortex
by: Abeeb Oyesiji Abiodun, et al.
Published: (2023-09-01)

Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension
by: Timothy WR Doulton, et al.
Published: (2009-12-01)

Medicinal chemistry of the renin-angiotensin system /
by: Timmermans, P. B. M. W. M., et al.
Published: (1994)

The renin-angiotensin system in obesity hypertension
by: Arya M Sharma, et al.
Published: (2001-03-01)

The renin-angiotensin-aldosterone system and fibrinolysis
by: Dirk C Felmeden, et al.
Published: (2000-09-01)

Effects of Statins on Renin–Angiotensin System
by: Nasim Kiaie, et al.
Published: (2021-07-01)

Nanoparticle approaches for the renin-angiotensin system
by: Sajini D. Hettiarachchi, PhD, et al.
Published: (2023-06-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01)

Different Sides of Renin Angiotensin System
by: Ceylan Ayada, et al.
Published: (2015-08-01)

Within the Brain: The Renin Angiotensin System
by: LaDonya Jackson, et al.
Published: (2018-03-01)

Blood pressure and plasma renin activity responses to different strategies to inhibit the renin-angiotensin-aldosterone system during exercise
by: Bryan Williams, et al.
Published: (2013-03-01)

Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.
by: Turnbull, F, et al.
Published: (2007)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
by: Kehoe, P, et al.
Published: (2007)

Review: Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment
by: Niels Holmark Andersen, et al.
Published: (2001-09-01)

Which strategy in inhibition of the renin-angiotensin system is the most efficient for heart failure?
by: Toshio Ogihara, et al.
Published: (2008-09-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)